Background The utilization of the Gustave Roussy Immune Score (GRIm-Score) in patient
selection for immunotherapy was initially reported. The objective of this retrospective study is …

Ocular metastases are the most frequent ocular malignant tumors; their prevalence is
estimated around 5–10% and is even higher in patients with breast or lung cancer. They …

Patients with metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell
lung cancer (NSCLC) are widely treated with osimertinib, the preferred first-line treatment …

Objective To evaluate the cost-effectiveness of the implementation of national lung cancer
(LC) screening programme (SP) in a high-risk population from the perspective of the …

Introduction. We aimed to evaluate whether circulating tumor cells (CTCs) were the
prognostic indicator responsible for chemotherapy and survival of NSCLC patients …

Objectives. Uncertainty in survival prediction beyond trial follow-up is highly influential in
cost-effectiveness analyses of oncology products. This research provides an empirical …

Purpose As for local advanced non-small cell lung cancer (NSCLC), synchronous
radiotherapy and chemotherapy is the standard treatment mode. But for patients with …

Background: Non-small cell lung cancer (NSCLC) accounts for the majority of lung cancer
but with a low early diagnosis rate. With immunotherapy becomes popular in lung cancer …

Objectives To develop efficient approaches for fitting network meta-analysis (NMA) models
with time-varying hazard ratios (such as fractional polynomials and piecewise constant …

Introduction A literature review was undertaken to identify clinical trials and real-world
studies of patients with stage IV NSCLC who had progressed on or after treatment with …